Alopecia areata.
Study Design
- Studientyp
- Review
- Population
- critically ill patients
- Intervention
- Alopecia areata. None
- Vergleichsgruppe
- None
- Primärer Endpunkt
- anemia/iron status
- Wirkungsrichtung
- Mixed
- Verzerrungsrisiko
- Unclear
Abstract
Alopecia areata is an asymptomatic, nonscarring hair loss with spontaneous remissions and exacerbations. Although the etiology is unknown, the disorder is associated with vitiligo, atopy, pernicious anemia, Down syndrome and thyroiditis. The area of hair loss may remain localized or may involve the entire scalp or all body hair. Treatment is difficult to assess because of individual response and spontaneous remissions, as well as a high rate of relapse. Intralesional injection of corticosteroids is the most common mode of treatment, although systemic steroid therapy, contact allergens, minoxidil, psoralens plus ultraviolet light, and other agents have been tried.
Zusammenfassung
Alopecia areata is an asymptomatic, nonscarring hair loss with spontaneous remissions and exacerbations that is associated with vitiligo, atopy, pernicious anemia, Down syndrome and thyroiditis.
Used In Evidence Reviews
Similar Papers
Annual review of nutrition · 2004
Secular trends in dietary intake in the United States.
Journal of the American Academy of Dermatology · 2002
A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men.
Journal of the American Academy of Dermatology · 2017
The effectiveness of treatments for androgenetic alopecia: A systematic review and meta-analysis.
Current problems in dermatology · 2015
Alopecia areata.
Drug design, development and therapy · 2019
Minoxidil and its use in hair disorders: a review.
Journal of cosmetic dermatology · 2021